Article
EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Aug 2024
Hu Li-Yang, Zhuang Wei-Tao, Chen Mao-Jian, Liao Jun, Wu Dong-Fang, Zhang Ya-Xiong, Pang Lan-Lan, Huang Yi-Hua, Mao Tian-Qin, Yang Meng-Juan, Peng Pei-Jian, Liang Jin-Xia, Chen Liang, Zeng Lin-Juan, Zhang Li, Fang Wen-Feng
Abstract excerpt
INTRODUCTION: EGFR-mutated NSCLC is characterized by an immunosuppressive microenvironment that confers limited clinical effectiveness to anti-PD-1 or PD-L1 antibodies. Despite the discouraging outcomes of immunotherapy, novel immune checkpoints are constantly emerging, among which the specific vulnerability for therapeutic intervention in the context of EGFR-mutated NSCLC remains unresolved. METHODS: Data sets...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
